These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25438456)

  • 21. [An outline of laboratory tests for autoimmune disorders].
    Misaki Y
    Rinsho Byori; 2003 Feb; Suppl 124():57-65. PubMed ID: 12710033
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
    Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
    Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and Clinical Significance of Anti-DFS70 in Antinuclear Antibody (ANA)-positive Patients Undergoing Routine ANA Testing in a New Zealand Public Hospital.
    Lucas S; Chang WL; Merien F
    J Rheumatol; 2018 Feb; 45(2):289-291. PubMed ID: 29419453
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of autoantibody testing.
    Aggarwal A
    Best Pract Res Clin Rheumatol; 2014 Dec; 28(6):907-20. PubMed ID: 26096093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological tests in autoimmune rheumatic disease.
    Isenberg DA
    Br J Hosp Med; 1993 Sep 15-Oct 5; 50(6):315-20. PubMed ID: 8242215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rational laboratory diagnosis in clinical immunology and rheumatology].
    Saal JG; Dürk H
    Internist (Berl); 1994 Jul; 35(7):633-9. PubMed ID: 7928165
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunologic tests: Anti-mitotic spindle associated antibody].
    Obayashi H; Wada T; Ohta M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():608-10. PubMed ID: 16111346
    [No Abstract]   [Full Text] [Related]  

  • 29. Laboratory tests for rheumatic diseases. When are they useful?
    Callegari PE; Williams WV
    Postgrad Med; 1995 Apr; 97(4):65-8, 71-4. PubMed ID: 7716093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of immunologic testing in suspected rheumatologic disease.
    Bhagat M; Sehra ST; Shahane A; Kwan M
    Curr Allergy Asthma Rep; 2014 Jan; 14(1):405. PubMed ID: 24370946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders.
    Stinton LM; Fritzler MJ
    Autoimmun Rev; 2007 Nov; 7(1):77-84. PubMed ID: 17967730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DFS70 Autoantibodies are Rare in Healthy Danish Individuals but may Still Serve as a Diagnostic Aid.
    Nilsson AC; Voss A; Lillevang ST
    Scand J Immunol; 2015 Dec; 82(6):547-8. PubMed ID: 26354722
    [No Abstract]   [Full Text] [Related]  

  • 33. A novel cost effective algorithm for antinuclear antibody (ANA) testing in an outpatient setting.
    Barak M; Rozenberg O; Grinberg M; Reginashvili D; Kishinewsky M; Henig C; Froom P
    Clin Chem Lab Med; 2013 Jul; 51(7):e163-5. PubMed ID: 23045381
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antinuclear antibodies and non-equivalent assays].
    Heegaard NH
    Ugeskr Laeger; 2007 Dec; 169(51):4481; author reply 4481-2. PubMed ID: 18213914
    [No Abstract]   [Full Text] [Related]  

  • 35. From ANA to ENA: how to proceed?
    Damoiseaux JG; Tervaert JW
    Autoimmun Rev; 2006 Jan; 5(1):10-7. PubMed ID: 16338206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antinuclear antibodies in infectious diseases.
    Im JH; Chung MH; Park YK; Kwon HY; Baek JH; Lee SY; Lee JS
    Infect Dis (Lond); 2020 Mar; 52(3):177-185. PubMed ID: 31718355
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibodies to hnRNPs in patients with a systemic rheumatic disease with no antibodies to extractable nuclear antigens or dsDNA.
    De Beéck KO; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
    Rheumatology (Oxford); 2012 Aug; 51(8):1515-6. PubMed ID: 22661555
    [No Abstract]   [Full Text] [Related]  

  • 38. Fatigue severity in anti-nuclear antibody-positive individuals does not correlate with pro-inflammatory cytokine levels or predict imminent progression to symptomatic disease.
    Hafiz W; Nori R; Bregasi A; Noamani B; Bonilla D; Lisnevskaia L; Silverman E; Bookman AAM; Johnson SR; Landolt-Marticorena C; Wither J
    Arthritis Res Ther; 2019 Nov; 21(1):223. PubMed ID: 31685018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of anti-ENA and anti-dsDNA antibodies using line immunoassay in systemic autoimmune diseases].
    Kim JM; Ihm CH; Sin DH; Ihm MK; Sim SC
    Korean J Lab Med; 2008 Oct; 28(5):353-61. PubMed ID: 18971616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of autoantibodies to extractable nuclear antigens in autoimmune diseases of rheumatic origin using immunoblotting--comparison with counter-electrophoresis].
    Hiepe F; Kiessig ST; Yamamoto K; Prokop G; Mielke F; Lukowsky A; Schlaak B; Miyamoto T; Apostoloff E
    Z Rheumatol; 1990; 49(5):304-9. PubMed ID: 2080688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.